NicOx SA  

(Public, EPA:COX)   Watch this stock  
Find more results for Jerry Cox�
2.00
-0.01 (-0.45%)
Real-time:   3:24PM GMT+1
EPA real-time data - Disclaimer
Currency in EUR
Range 1.96 - 2.04
52 week 1.71 - 2.93
Open 2.01
Vol / Avg. 254,485.00/383,030.00
Mkt cap 197.99M
P/E     -
Div/yield     -
EPS -0.33
Shares 72.96M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -613.72% -2429.05%
Operating margin -590.64% -2352.88%
EBITD margin - -2274.16%
Return on average assets -50.46% -23.45%
Return on average equity -58.39% -26.18%
Employees 101 -
CDP Score - -

Address

Drakkar 2 - Batiment D 2405 route des Dolines CS 10313 Sophia Antipolis
VALBONNE, 06560
France
+33-4-97245300 (Phone)
+33-4-97245399 (Fax)

Website links

Description

NicOx SA is a France-based biopharmaceutical company engaged in the research, development and future commercialization of investigational drugs for the treatment of inflammatory, cardio metabolic and ophthalmological diseases. It specializes in the nitric oxide-donating technology. The Company�s main products include Naproxcinod, NCX 116 and NCX 6560. Naproxcinod is a nitric oxide-donating compound, which is used in the treatment of signs and symptoms of osteoarthritis. NCX 116 is a nitric oxide-donating prostaglandin F2-alpha analog developed for the potential treatment of glaucoma (a group of eye diseases). NCX 6560 is a nitric oxide-donating derivative which is used to reduce the risk of cardiac events in heart patients. NicOx SA's other products also include nitric oxide-donating NCEs, developed in partnership with Merck & Co and NCX 1047. It offers also Doliage and Carragelose anti-viral eye drop program. The Company has such subsidiaries as Eupharmed and Aciex Therapeutics Inc.

Officers and directors

Michele Garufi Chairman of the Board and Chief Executive Officer, Member of the Management Committee
Age: 59
Eric Castaldi Financial Director and Member of the Management Committee
Philippe Masquida Executive Vice President, Managing Director of European Operations and Member of the Management Board
Age: 50
Jerry St. Peter Executive Vice President and General Manager of NicOx Inc, Member of the Management Committee
Age: 45
Pascal Pfister Chief Scientific Officer and Member of the Management Committee
Age: 54
Gavin Spencer Executive Vice President Corporate Development and Member of the Management Committee
Age: 43
Elizabeth Robinson Chairman of NicOx Research Institute Srl and Member of the Management Committee
Age: 57
Vicente Anido Jr.,Ph.D. Director
Age: 51
Jean-Francois Labbe Director
Age: 63
Bengt Samuelsson Director
Age: 78